Comment re: "Sporadic aberrant crypt foci are not a surrogate endpoint for colorectal adenoma prevention" and "aberrant crypt foci in the adenoma prevention with celecoxib trial"

Peter Lance, Stanley R. Hamilton

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Comment re: "Sporadic aberrant crypt foci are not a surrogate endpoint for colorectal adenoma prevention" and "aberrant crypt foci in the adenoma prevention with celecoxib trial"'. Together they form a unique fingerprint.